Market Overview

Morning Market Movers

Related RPRX
UPDATE: Ascendiant Capital Markets Reiterates On Repros Therapeutics Following Positive Topline Results
Williams-Sonoma Dips On Downbeat Q3 Forecast; Signet Jewelers Shares Jump
Related KYTH
CORRECTION: Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015
Kythera Reports FDA Acceptance of ATX-101 NDA, PDUFA Date Set at May 13, 2015

Repros Therapeutics (NASDAQ: RPRX) moved up 26.15% to $26.82 after the company announced topline results from both the second pivotal efficacy study as well as the 6 month safety study of Androxal®.

Kythera Biopharmaceuticals (NASDAQ: KYTH) jumped 24.43% to $41.72 after the company reported positive ATX-101 top line phase III trial results for the reduction of submental fat.

Agenus (NASDAQ: AGEN) rose 22.99% to $3.37 after the company reported positive follow-on Phase 2 results for brain cancer vaccine.

Aeropostale (NYSE: ARO) shares jumped 18.23% to $10.18 after private equity firm Sycamore Partners bought a 7.96% stake in the company.

Posted-In: Morning Market MoversNews Intraday Update Markets Movers

 

Related Articles (AGEN + ARO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters